Escalon Medical Corp. (OTCMKTS:ESMC – Get Rating)’s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.08 and traded as low as $0.06. Escalon Medical shares last traded at $0.06, with a volume of 18,500 shares.
Escalon Medical Price Performance
The company has a 50-day simple moving average of $0.08 and a 200-day simple moving average of $0.09. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.27 and a quick ratio of 0.76.
Escalon Medical (OTCMKTS:ESMC – Get Rating) last released its quarterly earnings data on Monday, November 14th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The business had revenue of $2.61 million during the quarter. Escalon Medical had a negative return on equity of 77.30% and a negative net margin of 5.83%.
Escalon Medical Company Profile
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.
Further Reading
- Get a free copy of the StockNews.com research report on Escalon Medical (ESMC)
- Bloom Energy Powers Up After an Upgrade, is it Worth the Risk?
- Why Hershey Is a Sweet Recession Stock
- Will Amazon Stock Be Delivering for Investors in 2023?
- The Analysts Shift Trucking Sentiment Back into Forward
- The Institutions Book A Flight With Boeing
Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.